Identification of HLA-A11-restricted HIV-1-specific cytotoxic T-lymphocyte epitopes in China

被引:6
|
作者
Wang, Shaoyang
Sun, Yongtao [1 ]
Zhai, Song
Zhuang, Yan
Zhao, Shuguang
Kang, Whenzhen
Li, Xinhong
Huang, Dedong
Yu, Xu G.
Walker, Bruce D.
Altfeld, Marcus A.
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710038, Peoples R China
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA
关键词
HIV; cytotoxic T-lymphocyte; epitopes; enzyme-linked immunospot (ELISPOT) assay; intracellular gamma interferon staining (ICS);
D O I
10.2174/157016207779316404
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To fully define HLA-All-restricted HIV-1- specific cytotoxic T-lymphocyte epitopes in China, a method combining the enzyme-linked immunospot (ELISPOT) assay with intracellular gamma interferon staining (ICS) of peripheral blood mononuclear cells (PBMC) was used to map the optimal epitopes targeted by ELISPOT and then to define the FILA restriction of epitopes by ICS. A novel HLA-All-restricted CTL epitope and five other published HLA-All -restricted epitopes previously identified by reverse immunogenetics or other methods were defined. The approach of integrating ELISPOT with ICS is both convenient and useful for the characterization of CTL responses to HIV-1 infection; this method is practical for defining novel epitopes and facilitates in developing new strategies for future vaccine design in China and other Asian countries.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 50 条
  • [1] Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes
    Longmate, J
    York, J
    La Rosa, C
    Krishnan, R
    Zhang, M
    Senitzer, D
    Diamond, DJ
    IMMUNOGENETICS, 2001, 52 (3-4) : 165 - 173
  • [2] DIFFERENT PATTERNS OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY AFTER PRIMARY INFECTION
    LAMHAMEDICHERRADI, S
    CULMANNPENCIOLELLI, B
    GUY, B
    LY, TD
    GOUJARD, C
    GUILLET, JG
    GOMARD, E
    AIDS, 1995, 9 (05) : 421 - 426
  • [3] Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones
    Balamurugan, Arumugam
    Ng, Hwee L.
    Yang, Otto O.
    JOURNAL OF VIROLOGY, 2018, 92 (16)
  • [4] Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin
    Yang, Zhao
    Zhao, Tianzhi
    Liu, Yong
    Gong, Zili
    Cheng, Saiyu
    Yang, Qingwu
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 51 - 58
  • [5] Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin
    Zhao Yang
    Tianzhi Zhao
    Yong Liu
    Zili Gong
    Saiyu Cheng
    Qingwu Yang
    Journal of Neuro-Oncology, 2013, 114 : 51 - 58
  • [6] Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes
    Goulder, PJR
    Reid, SW
    Price, DA
    OCallaghan, CA
    McMichael, AJ
    Phillips, RE
    Jones, EY
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (06) : 1515 - 1521
  • [7] Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan
    Shao, Gaohai
    Liu, Qingjun
    Yang, Ling
    Feng, Guibo
    Zhao, Wang
    Huang, Zhongyan
    Yang, Zhao
    JOURNAL OF INFLAMMATION-LONDON, 2020, 17 (01):
  • [8] Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan
    Gaohai Shao
    Qingjun Liu
    Ling Yang
    Guibo Feng
    Wang Zhao
    Zhongyan Huang
    Zhao Yang
    Journal of Inflammation, 17
  • [9] Identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8
    Li, Shufa
    Li, Haiying
    Chen, Bing
    Lu, Debin
    Deng, Wuquan
    Jiang, Youzhao
    Zhou, Zhongqi
    Yang, Zhao
    VACCINE, 2013, 31 (12) : 1610 - 1615
  • [10] IL-7 ENHANCEMENT OF ANTIGEN-DRIVEN ACTIVATION EXPANSION OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE PRECURSORS (CTLP)
    FERRARI, G
    KING, K
    RATHBUN, K
    PLACE, CA
    PACKARD, MV
    BARTLETT, JA
    BOLOGNESI, DP
    WEINHOLD, KJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 101 (02): : 239 - 248